These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 8111801)
1. Glucose and lipid metabolism during long-term antihypertensive treatment with indapamide in non-insulin-dependent diabetic patients. Fujii S; Kaku K; Andou S; Nakayama H; Suetsugu N; Inoue M; Yoshizaki Y; Matsuda M; Tanaka M; Okafuji S Clin Ther; 1993; 15(6):1041-50. PubMed ID: 8111801 [TBL] [Abstract][Full Text] [Related]
2. Effect of indapamide SR in the treatment of hypertensive patients with type 2 diabetes. Kuo SW; Pei-Dee ; Hung YJ; Hsieh AT; Wu LY; Hsieh CH; He CT; Yang TC; Lian WC Am J Hypertens; 2003 Aug; 16(8):623-8. PubMed ID: 12878366 [TBL] [Abstract][Full Text] [Related]
3. [Combined antihypertensive therapy in patients with arterial hypertension and type 2 diabetes]. Nesterov IuI; Poltavtseva OV; Bondareva IN; Tepliakov AT Klin Med (Mosk); 2009; 87(8):29-32. PubMed ID: 19827527 [TBL] [Abstract][Full Text] [Related]
4. Indapamide in the treatment of hypertension in non-insulin-dependent diabetes. Raggi U; Palumbo P; Moro B; Bevilacqua M; Norbiato G Hypertension; 1985; 7(6 Pt 2):II157-60. PubMed ID: 4077234 [TBL] [Abstract][Full Text] [Related]
5. [Combined antihypertensive treatment of patients with hypertension and type 2 diabetes mellitus]. Nesterov IuI; Bondareva IN; Tepliakov AT; Poltavtseva OV Ter Arkh; 2009; 81(2):75-9. PubMed ID: 19334497 [TBL] [Abstract][Full Text] [Related]
6. The Results of ACES (Antihypertensive Combinations' Long Term Efficacy Comparing Study): Analysis of Metabolic Effects of Antihypertensive Combination Therapies. Nádházi Z; Dézsi CA Clin Drug Investig; 2016 Oct; 36(10):819-27. PubMed ID: 27405983 [TBL] [Abstract][Full Text] [Related]
7. Antihypertensive therapy in diabetic patients. The use of indapamide. Harrower AD; McFarlane G Am J Med; 1988 Jan; 84(1B):89-91. PubMed ID: 3277423 [TBL] [Abstract][Full Text] [Related]
8. Effect of indapamide on blood pressure and glucose tolerance in non-insulin-dependent diabetes. Harrower AD; McFarlane G; Donnelly T; Gray CE Hypertension; 1985; 7(6 Pt 2):II161-3. PubMed ID: 3908319 [TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism. Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914 [TBL] [Abstract][Full Text] [Related]
10. Treatment of Hypertensive Patients With Diabetes and Microalbuminuria With Combination Indapamide SR/Amlodipine: Retrospective Analysis of NESTOR. Hanon O; Boully C; Caillard L; Labourée F; Cochiello S; Chaussade E Am J Hypertens; 2015 Aug; 28(8):1064-71. PubMed ID: 25628416 [TBL] [Abstract][Full Text] [Related]
11. Doxazosin reduces prevalence of small dense low density lipoprotein and remnant-like particle cholesterol levels in nondiabetic and diabetic hypertensive patients. Hirano T; Yoshino G; Kashiwazaki K; Adachi M Am J Hypertens; 2001 Sep; 14(9 Pt 1):908-13. PubMed ID: 11587157 [TBL] [Abstract][Full Text] [Related]
12. Combination of an ACE inhibitor and indapamide improves blood pressure control, but attenuates the beneficial effects of ACE inhibition on plasma adiponectin in patients with essential hypertension. Huang SS; Wu TC; Lin SJ; Chen JW Circ J; 2009 Dec; 73(12):2282-7. PubMed ID: 19789415 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of telmisartan and nifedipine gastrointestinal therapeutic system on blood pressure control, glucose metabolism, and the lipid profile in patients with type 2 diabetes mellitus and mild hypertension: a 12-month, randomized, double-blind study. Derosa G; Cicero AF; Bertone G; Piccinni MN; Fogari E; Ciccarelli L; Fogari R Clin Ther; 2004 Aug; 26(8):1228-36. PubMed ID: 15476904 [TBL] [Abstract][Full Text] [Related]
15. [Effect of antihypertensive combinations on arterial pressure, albuminuria, and glycemic control in patients with type II diabetic nephropathy: a randomized study]. Goicolea I; Fernández González R; Piniés J; Garrido J; Martínez JM; Armenteros S; Moreno Carretero E Nefrologia; 2002; 22(2):170-8. PubMed ID: 12085418 [TBL] [Abstract][Full Text] [Related]
16. Improved insulin action and glycemic control after long-term angiotensin-converting enzyme inhibition in subjects with arterial hypertension and type II diabetes. Torlone E; Britta M; Rambotti AM; Perriello G; Santeusanio F; Brunetti P; Bolli GB Diabetes Care; 1993 Oct; 16(10):1347-55. PubMed ID: 8269792 [TBL] [Abstract][Full Text] [Related]
17. Effects of long-term cilazapril treatment on glucose and lipid metabolism in hypertensive patients with non-insulin-dependent diabetes mellitus. Uchida K; Kigoshi T; Ishii T; Kitazawa M; Nakano S; Morimoto S Clin Ther; 1995; 17(4):729-34. PubMed ID: 8565036 [TBL] [Abstract][Full Text] [Related]
18. A review of 10 years of experience with indapamide as an antihypertensive agent. Thomas JR Hypertension; 1985; 7(6 Pt 2):II152-6. PubMed ID: 4077233 [TBL] [Abstract][Full Text] [Related]
19. [Clinical assessment of metabolic effects of antihypertensive therapy]. Tkacheva ON; Shumbutova AIu; Novikova IM; Samsonenko NS; Guseva KIu Kardiologiia; 2008; 48(3):34-8. PubMed ID: 18429754 [No Abstract] [Full Text] [Related]
20. Effects of indapamide versus hydrochlorothiazide on plasma lipids and lipoproteins in hypertensive patients: a direct comparison. Spence JD; Huff M; Barnett PA Can J Clin Pharmacol; 2000; 7(1):32-7. PubMed ID: 10822211 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]